Sunday, May 24, 2020 11:22:48 AM
Have to disagree there Sukus.
It's true that countries like Brazil and Russia are now experiencing their first wave.
But pick any European country you like. Steady and persistent decline in deaths for at least the last month. Countries that have re-opened schools, workplaces etc, haven't seen a noticeable second wave.
Countries that had strict lockdowns may have a small second wave of cases, but those who were more relaxed won't.
Collective acquired immunity is now calculated to be reached after only 20% case rate.
This is because most with innate immunity (kids, and most healthy adults weren't susceptible in the first place.
Many European countries are already virtually there.
London's new cases and deaths have slowed to a trickle.
Continuing lockdowns simply prolong the agony, weaken immune systems and decimate economies into the bargain.
I'll stick my neck out and say a 'cure' will be unnecessary.
It's true that countries like Brazil and Russia are now experiencing their first wave.
But pick any European country you like. Steady and persistent decline in deaths for at least the last month. Countries that have re-opened schools, workplaces etc, haven't seen a noticeable second wave.
Countries that had strict lockdowns may have a small second wave of cases, but those who were more relaxed won't.
Collective acquired immunity is now calculated to be reached after only 20% case rate.
This is because most with innate immunity (kids, and most healthy adults weren't susceptible in the first place.
Many European countries are already virtually there.
London's new cases and deaths have slowed to a trickle.
Continuing lockdowns simply prolong the agony, weaken immune systems and decimate economies into the bargain.
I'll stick my neck out and say a 'cure' will be unnecessary.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
